Biolargo, Inc.
BLGO· OTC
Filed May 15, 2013 · 10-Q · 45 days after period end · 0001437749-13-006010
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $14.36K | $30.82K | $9.52K |
| Net Income | -$645.30K | -$920.97K | -$1.44M |
| EPS Diluted | -$0.01 | -$0.02 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 15, 2013 · 45 d after period end